HomeInsightsStock Comparison

Lupin Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Lupin Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Last Updated on: May 02, 2025

Key Highlights

  • The Latest Trading Price of Lupin Ltd is ₹ 2094 as of 02 May 09:09.
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 38.5 on March 2024 . This represents a CAGR of 0.26% over 4 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Lupin Ltd changed from ₹ 26713 crore on March 2020 to ₹ 73722 crore on March 2024 . This represents a CAGR of 22.51% over 5 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 12005 crore on March 2024 . This represents a CAGR of 43.58% over 2 years.
  • The revenue of Lupin Ltd for the Dec '24 is ₹ 5821 crore as compare to the Sep '24 revenue of ₹ 5715 crore. This represent the growth of 1.86% The revenue of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ 15.1 crore as compare to the Sep '24 revenue of ₹ 12.9 crore. This represent the growth of 17.05%.
  • The ebitda of Lupin Ltd for the Dec '24 is ₹ 1409 crore as compare to the Sep '24 ebitda of ₹ 1382 crore. This represent the growth of 1.95% The ebitda of Sun Pharma Advanced Research Company Ltd for the Dec '24 is ₹ -73.5 crore as compare to the Sep '24 ebitda of ₹ -102 crore. This represent the decline of -28.55%.
  • The net profit of Lupin Ltd changed from ₹ 453.33 crore to ₹ 858.86 crore over 7 quarters. This represents a CAGR of 44.07% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -79.51 crore over 7 quarters. This represents a CAGR of -9.86% .
  • The Dividend Payout of Lupin Ltd changed from 37.36 % on March 2020 to 15.67 % on March 2024 . This represents a CAGR of -15.95% over 5 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd. (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the Company with effect from Appointed date on February 28, 2007.

Lupin Ltd News Hub

News

Lupin announces board meeting date

Lupin will hold a meeting of the Board of Directors of the Company on 14 May 2025. Powered...

Read more

30 Apr 2025 11:10

News

Lupin receives USFDA approval for Tolvaptan Tablets

 Lupin has received approval from the United States Food and Drug Administration (U.S. FDA...

Read more

24 Apr 2025 11:06

News

Lupin rallies after receiving USFDA nod for Tolvaptan tablets

The drug is bioequivalent to Jynarque' Tablets by Otsuka Pharmaceutical Company. Lupin is ...

Read more

24 Apr 2025 11:40

News

Lupin gets EIR from USFDA for Nagpur facility

The EIR was issued following an inspection of the facility conducted from 10 June to 13 Ju...

Read more

17 Apr 2025 15:00

News

Lupin allots 24,101 equity shares under ESOP

Lupin has allotted 24,101 equity shares under ESOP on 21 March 2025. In view of the above,...

Read more

21 Mar 2025 16:10

News

Nanomi wins prestigious CMO Award for Life Science Leadership in Drug Delivery

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin, today announced that it ...

Read more

21 Mar 2025 19:12

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

News

Volumes jump at Sun Pharma Advanced Research Company Ltd counter

Kalpataru Projects International Ltd, Inox Wind Ltd, Data Patterns (India) Ltd, Triveni Tu...

Read more

07 Mar 2025 14:30

News

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

01 Feb 2025 10:56

News

Sun Pharma Advanced Research Company to acquire 55% stake in Tiller Therapeutics

Sun Pharma Advanced Research Company announced the signing of a binding Letter of Intent (...

Read more

17 Dec 2024 09:34

News

Sun Pharma inks pact with UCSF and Tiller Therapeutics

The LoI outlines the key terms of license and rights for development and commercialization...

Read more

17 Dec 2024 10:24

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lupin Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Lupin Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Lupin Ltd is 95,634 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 4,736 Cr

What are the key factors driving the stock performance of Lupin Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Lupin Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Sun Pharma Advanced Research Company Ltd?

As of May 2, 2025, the Lupin Ltd stock price is INR ₹2094.65. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹145.95.

How do dividend payouts of Lupin Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Lupin Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions